Skip to main content
Equibles

ALGERT GLOBAL LLC

Position in IMVT — Immunovant, Inc.

CIK 1275218 SAN FRANCISCO, CA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,158,635
+$3,531,309 QoQ
Shares Held
159,840
+51.1% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#48
of 226 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. IMVT ranks #37 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCVX
Vaxcyte, Inc.
 515,343 $29,956,888
2 ROIV
Roivant Sciences Ltd.
 845,118 $29,908,726
3 XENE
Xenon Pharmaceuticals Inc.
 419,773 $25,337,498
4 CLDX
Celldex Therapeutics, Inc.
 647,836 $24,105,977
5 AXSM
Axsome Therapeutics, Inc.
 95,335 $23,335,147
6 SNDX
Syndax Pharmaceuticals Inc
 1,051,465 $22,985,024
7 MRNA
Moderna, Inc.
 274,820 $19,245,644
8 MLYS
Mineralys Therapeutics, Inc.
 649,027 $17,510,748

All Filings in IMVT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,158,635 159,840
2026-03-31 $2,627,326 105,770
2025-09-30 $562,588 34,900
2024-09-30 $1,053,986 36,969
2024-06-30 $3,192,763 120,938
2024-03-31 $1,669,134 51,660
2023-12-31 $2,092,217 49,661
2023-09-30 $2,436,574 63,469
2023-06-30 $1,511,131 79,659
2023-03-31 $607,821 39,189
2022-09-30 $461,694 82,741
2022-06-30 $492,180 126,200
2022-03-31 $751,161 136,327
2021-06-30 $303,464 28,710
2021-03-31 $1,076,492 67,113